Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
memo - Magazine of European Medical Oncology
Published in: memo - Magazine of European Medical Oncology 1/2024

01-02-2024 | Checkpoint Inhibitors | editorial

“Navigating the evolving landscape of cancer treatment: a triad of progress”

Author: Ass. Prof. PD. Dr. Andreas Pircher, PhD

Published in: memo - Magazine of European Medical Oncology | Issue 1/2024

Login to get access

Excerpt

In recent years, the treatment paradigms for locally advanced rectal cancer, early breast cancer, and early-stage non-small-cell lung cancer (NSCLC) have undergone significant transformations. The traditional approaches, although effective, faced challenges such as tumor recurrence and quality-of-life issues. Now, a nuanced understanding of the unique characteristics of each cancer has paved the way for personalized interventions. …
Literature
1.
Piringer G. Total neoadjuvant therapy for each local advanced rectal cancer? memo. 2024;17(1).
2.
3.
Wass R, Hochmair M, Lang D, Horner A, Lamprecht B. (Neo)adjuvant approaches in lung cancer—paving the road to cure. memo. 2024;17(1).
Metadata
Title
“Navigating the evolving landscape of cancer treatment: a triad of progress”
Author
Ass. Prof. PD. Dr. Andreas Pircher, PhD
Publication date
01-02-2024
Publisher
Springer Vienna
Published in
memo - Magazine of European Medical Oncology / Issue 1/2024
Print ISSN: 1865-5041
Electronic ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-023-00952-8

Other articles of this Issue 1/2024

memo - Magazine of European Medical Oncology 1/2024 Go to the issue

case report

Acute myeloid leukemia patient with active disseminated tuberculosis bridged to transplant with reduced 14-day venetoclax and azacitidine schedule

short review

Metastasis-directed therapy: new standard or too early to change paradigm?

short review

Evidence and emerging trends in local therapy for metastatic hormone-sensitive prostate cancer: a narrative review

short review

(Neo)adjuvant approaches: pavement on the road to cure—breast cancer

short review

Genetic testing and management of prostate cancer patients with pathogenic germline variants

special report

Cellular and humoral responses to fourth SARS-CoV-2 vaccination in a real-life cohort of patients with cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits